Skip Navigation


QJM Advance Access originally published online on July 22, 2005
QJM 2005 98(9):643-654; doi:10.1093/qjmed/hci098
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
98/9/643    most recent
hci098v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by MacLaren, K.
Right arrow Articles by Ballardie, F.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacLaren, K.
Right arrow Articles by Ballardie, F.W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Primary angiitis of the central nervous system: emerging variants

K. MacLaren, J. Gillespie1, S. Shrestha, D. Neary2 and F.W. Ballardie

Departments of General Medicine, 1Radiology, and 2Neurology, Manchester Royal Infirmary, Manchester, UK

Address correspondence to Dr F.W. Ballardie, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL. email: francis.ballardie{at}cmmc.nhs.uk

Received 21 December 2004 and in revised form 9 April 2005

Background: Primary angiitis of the central nervous system (PACNS), a serious disease, has not featured prominently in the spectrum of multi-organ disease seen in vasculitis clinics.

Aim: To evaluate the presentation, natural history and features of PACNS variants and compare to those of systemic vasculitides.

Design: Retrospective analysis.

Methods: Patients (n = 105) presented during 1988–2003 to a tertiary regional vasculitis clinic receiving unselected disease types. Data were collected from a clinical database, patient and laboratory records.

Results: The frequency of PACNS presentation rose over the study period, compared with most of the other vasculitides. When PACNS was divided into small- and middle-sized vessel disease (SVD/MVD), their clinical courses differed substantially. SVD PACNS was responsive to immunosuppressive drugs, but relapsed during prolonged periods in all patients on maintenance immunosuppressives, or after withdrawal of treatment, causing recurrent, severe and irreversible CNS injury. MVD PACNS had isolated episodes at presentation, with a paucity of relapses during prolonged follow-up.

Discussion: Similarities between SVD PACNS and microscopic polyarteritis suggest the former may represent a limited form of the latter. MVD PACNS has a distinctly more benign relapse pattern than its multisystem counterpart polyarteritis nodosa. Acute-phase serology was useful in designating inflammatory processes at presentation of patients presenting with encephalopathy caused by SVD only, but were unhelpful in defining relapses in this form of PACNS, the definition of which in all cases rested on clinical assessment and MR scanning. Direct cerebral angiography was not diagnostic in any case of SVD PACNS; positive brain biopsy is diagnostically unequivocal, but the total clinical syndrome with imaging may establish a diagnosis with highest probability. In MVD PACNS, angiography with MR scan proved diagnostic. We suggest an algorithm for a rational, minimally invasive approach to investigation. In PACNS, SVD and MVD are important variants, and decisions about therapy should incorporate these distinctions.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch NeurolHome page
J. Birnbaum and D. B. Hellmann
Primary Angiitis of the Central Nervous System
Arch Neurol, June 1, 2009; 66(6): 704 - 709.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M Arias, X. Osorio, D Dapena, S Arias-Rivas, and F Vazquez
Recurrent leukoencephalopathy with microhemorrhages: gradient-echo MRI study diagnostic value in CNS primary angiitis
Multiple Sclerosis, September 1, 2008; 14(8): 1139 - 1141.
[Abstract] [PDF]


Home page
Neuro Oncol DukeHome page
P. Kiewe, C. Loddenkemper, I. Anagnostopoulos, M. Reinwald, E. Thiel, and A. Korfel
High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma
Neuro-oncol, April 1, 2007; 9(2): 96 - 102.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. D. Dowell, J. D. Fleck, S. T. Vakili, and M. D. Benson
Familial oculoleptomeningeal amyloidosis associated with primary angiitis of the CNS
Neurology, January 2, 2007; 68(1): 77 - 78.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.